171 related articles for article (PubMed ID: 33795361)
1. Test and Prevent: Evaluation of a Pilot Program Linking Clients With Negative HIV Test Results to Pre-exposure Prophylaxis in Zimbabwe.
Stankevitz K; Nhamo D; Murungu J; Ridgeway K; Mamvuto T; Lenzi R; Lydon M; Katsande N; Mahaka I; Hoke T
Glob Health Sci Pract; 2021 Mar; 9(1):40-54. PubMed ID: 33795361
[TBL] [Abstract][Full Text] [Related]
2. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
3. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
Ortblad KF; Mogere P; Omollo V; Kuo AP; Asewe M; Gakuo S; Roche S; Mugambi M; Mugambi ML; Stergachis A; Odoyo J; Bukusi EA; Ngure K; Baeten JM
J Int AIDS Soc; 2023 Jun; 26(6):e26131. PubMed ID: 37306128
[TBL] [Abstract][Full Text] [Related]
4. Linking emergency department patients at risk for human immunodeficiency virus to pre-exposure prophylaxis.
Mahal J; Deccy S; Seu R
Am J Emerg Med; 2022 Apr; 54():87-90. PubMed ID: 35151016
[TBL] [Abstract][Full Text] [Related]
5. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
[TBL] [Abstract][Full Text] [Related]
6. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
[TBL] [Abstract][Full Text] [Related]
7. Human Enough: A Qualitative Study of Client Experience With Internet-Based Access to Pre-exposure Prophylaxis.
Hughes SD; Koester KA; Engesaeth E; Hawkins MV; Grant RM
J Med Internet Res; 2021 Jul; 23(7):e22650. PubMed ID: 36256828
[TBL] [Abstract][Full Text] [Related]
8. Peer PrEP referral + HIV self-test delivery for PrEP initiation among young Kenyan women: study protocol for a hybrid cluster-randomized controlled trial.
Wairimu N; Malen RC; Reedy AM; Mogere P; Njeru I; Culquichicón C; McGowan M; Gao F; Baeten JM; Ngure K; Ortblad KF
Trials; 2023 Nov; 24(1):705. PubMed ID: 37925450
[TBL] [Abstract][Full Text] [Related]
9. Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya.
Wanga V; Omollo V; Bukusi EA; Odoyo JB; Morton JF; Kidoguchi L; Johnson R; Hughes JP; Celum C; Baeten JM
J Int AIDS Soc; 2020 Aug; 23(8):e25561. PubMed ID: 32820597
[TBL] [Abstract][Full Text] [Related]
10. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics.
Irungu EM; Odoyo J; Wamoni E; Bukusi EA; Mugo NR; Ngure K; Morton JF; Mugwanya KK; Baeten JM; O'Malley G;
J Int AIDS Soc; 2021 Sep; 24(9):e25799. PubMed ID: 34496148
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda.
Nakalega R; Mukiza N; Menge R; Kizito S; Babirye JA; Kuteesa CN; Mawanda D; Mulumba E; Nabukeera J; Ggita J; Nakanjako L; Akello C; Mirembe BG; Lukyamuzi Z; Nakaye C; Kataike H; Maena J; Etima J; Nabunya HK; Biira F; Nagawa C; Heffron R; Celum C; Gandhi M; Mujugira A
BMC Public Health; 2023 Jun; 23(1):1163. PubMed ID: 37322510
[TBL] [Abstract][Full Text] [Related]
13. Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
Kiptinness C; Naik P; Thuo N; Malen RC; Dettinger JC; Pintye J; Rafferty M; Jomo E; Nyamasyo N; Wood T; Isabelli P; Morris S; Hattery D; Stergachis A; Were D; Sharma M; Ngure K; Mugambi ML; Ortblad KF
Front Public Health; 2023; 11():1054559. PubMed ID: 36908449
[TBL] [Abstract][Full Text] [Related]
14. Linking women experiencing incarceration to community-based HIV pre-exposure prophylaxis care: protocol of a pilot trial.
Ramsey SE; Ames EG; Brinkley-Rubinstein L; Teitelman AM; Clarke J; Kaplan C
Addict Sci Clin Pract; 2019 Mar; 14(1):8. PubMed ID: 30832717
[TBL] [Abstract][Full Text] [Related]
15. Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe.
Skovdal M; Magoge-Mandizvidza P; Dzamatira F; Maswera R; Nyamukapa C; Thomas R; Mugurungi O; Gregson S
BMC Infect Dis; 2022 Apr; 22(1):399. PubMed ID: 35461220
[TBL] [Abstract][Full Text] [Related]
16. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of HIV oral pre-exposure prophylaxis: findings from programmatic surveillance within two general population HIV programs in Nigeria.
Anyasi H; Idemudia A; Badru T; Onyegbule S; Isang E; Sanwo O; Pandey SR; Chiegil R; Bateganya M; Schwartz K; Njuguna N; Persaud N; Plotkin M; Iyortim I; Khamofu H
BMC Public Health; 2024 May; 24(1):1325. PubMed ID: 38755630
[TBL] [Abstract][Full Text] [Related]
18. The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.
Omollo V; Asewe M; Mogere P; Maina G; Kuo AP; Odoyo J; Oware K; Baeten JM; Kohler P; Owens T; Bukusi EA; Ngure K; Ortblad KF
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):379-386. PubMed ID: 37079900
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
[TBL] [Abstract][Full Text] [Related]
20. Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada.
Munasinghe LL; Toy J; Lepik KJ; Moore DM; Hull M; Bacani N; Sereda P; Barrios R; Montaner JSG; Lima VD
PLoS One; 2023; 18(3):e0283025. PubMed ID: 36920956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
